The Frost & Sullivan Institute Honors Global Organizations Advancing Sustainable Progress with the 2025 Visionary Growth Leadership Best Practices Recognition
SANTA CLARA, Calif., Dec. 9, 2025 /PRNewswire/ -- The Frost & Sullivan…
Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University
- First patient in the world treated with Alpha DaRT® in the…
Clarins launches its mobile app to elevate its customer relationship, in partnership with Merkle
PARIS, Dec. 9, 2025 /PRNewswire/ -- Clarins, the iconic family-owned global cosmetics group…
Digital Culture Group Dominates Awards Season With Wins in AI Innovation
Adweek Tech Stack Awards Recognize DCG’s ARI-Driven Success with Edmond’s Honor Bourbon…
Frontline Performance Group Launches CheckMax with AI Insights to Maximize F&B Profits
Bigger Profits, Better Service: CheckMax Tackles Top Restaurant Challenges ORLANDO, Fla., Dec. 9,…
Jiangyin Concludes Golden Autumn Investment Month with 208 Projects Totaling RMB68 Billion
JIANGYIN, China, Dec. 9, 2025 /PRNewswire/ -- The 2025 Jiangyin Symposium on…
Baqar’s Premier League 2025 Ignites Mumbai with a High-Voltage Cardio Night
Over 180+ global participants unite for an electrifying celebration of fitness, resilience,…
MICHELIN Guide Returns to Vegas with Launch of New Southwest Edition
LAS VEGAS - Announced today, in partnership with Arizona, Nevada, New Mexico,…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced…
